This compound is primarily used in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of antifungal agents, particularly those targeting fungal infections caused by pathogens like Candida and Aspergillus species. The compound's structure, featuring a difluorophenyl group, enhances its binding affinity to specific biological targets, making it valuable in drug design. Additionally, it is utilized in research settings to study enzyme inhibition and receptor interactions, contributing to the discovery of new therapeutic agents. Its chiral nature also makes it significant in the production of enantiomerically pure drugs, ensuring higher efficacy and reduced side effects.